Cargando…
Follistatin-like protein 1 functions as a potential target of gene therapy in proliferative diabetic retinopathy
The degree of retinal fibrosis increased in proliferative diabetic retinopathy (PDR) patients after administration of anti-Vascular endothelial growth factor (VEGF) injections. Previous studies showed that the balance between connective tissue growth factor (CTGF) and VEGF plays an important role. T...
Autores principales: | Niu, Rui, Nie, Ze-Tong, Liu, Lin, Chang, Yu-Wen, Shen, Jian-Qun, Chen, Qiong, Dong, Li-Jie, Hu, Bo-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034962/ https://www.ncbi.nlm.nih.gov/pubmed/33714952 http://dx.doi.org/10.18632/aging.202678 |
Ejemplares similares
-
Differential expression of follistatin and FLRG in human breast proliferative disorders
por: Bloise, Enrrico, et al.
Publicado: (2009) -
The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy
por: Zhu, Xuemei, et al.
Publicado: (2015) -
Therapeutic effect of lutein supplement on non-proliferative diabetic retinopathy: A retrospective study
por: Ren, Yong-bo, et al.
Publicado: (2019) -
Characterisation of the vitreous proteome in proliferative diabetic retinopathy
por: Wang, Hao, et al.
Publicado: (2012) -
Plasma metabolomic profiling of proliferative diabetic retinopathy
por: Zhu, Xiao-Rong, et al.
Publicado: (2019)